Genomic Testing in Adults With Undiagnosed Rare Conditions: Improvement of Diagnosis Using Clinical Exome Sequencing as a First‐Tier Approach

ABSTRACT Adult patients with undiagnosed genetic disorders suffer most from diagnostic delay and seldom appear in cohort studies investigating the diagnostic yield in medical genetic clinical practice. Here we present the results of the diagnostic activity performed in a referral center on 654 conse...

Full description

Saved in:
Bibliographic Details
Published inClinical genetics Vol. 108; no. 2; pp. 115 - 123
Main Authors Petillo, Roberta, De Maggio, Ilaria, Piscopo, Carmelo, Chetta, Massimiliano, Tarsitano, Marina, Chiriatti, Luigi, Sannino, Elvira, Torre, Serena, D'Antonio, Marcella, D'Ambrosio, Paola, Rambaldi, Marco, Cioce, Maria, De Stefano, Valentina, Parisi, Maria Rita, Telese, Antonella, Oro, Maria, Rivieccio, Maria, Radio, Francesca Clementina, Mancini, Cecilia, Niceta, Marcello, Cordeddu, Viviana, Bruselles, Alessandro, Mammì, Corrado, Dattola, Adele, Fioretti, Tiziana, Esposito, Gabriella, Novelli, Antonio, Tessitore, Alessandro, Tessa, Alessandra, Santorelli, Filippo Maria, Iolascon, Achille, Monica, Matteo Della, Tartaglia, Marco, Priolo, Manuela
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ABSTRACT Adult patients with undiagnosed genetic disorders suffer most from diagnostic delay and seldom appear in cohort studies investigating the diagnostic yield in medical genetic clinical practice. Here we present the results of the diagnostic activity performed in a referral center on 654 consecutive, unselected adult subjects presenting with molecularly unsolved conditions. More than 50% of the referred individuals were affected by syndromic or isolated intellectual disability. Different molecular approaches, including clinical/whole exome sequencing (CES/WES), chromosomal microarray analysis (CMA), and/or targeted gene or gene panel sequencing were used to analyze patients' DNA. Definitive diagnosis was obtained in over 30% of individuals. The most sensitive methodology was CES/WES, which allowed us to reach a diagnosis in over 50% of the 162 solved cases. Despite the great variety of clinical presentations, our results represent a reliable picture of the “real world” daily routine in an outpatient medical genetics clinic dedicated to diagnostic activity, and contribute to better understand the great value of a definitive molecular diagnosis in adults, either for the affected individuals and their families. This retrospective analysis demonstrates the importance of adopting a genomic‐first approach within the diagnostic process for adults affected with unsolved rare conditions. The diagnostic activity on 654 consecutive adult subjects presenting with molecularly unsolved conditions is reported. Definitive diagnosis was obtained in over 30% of individuals. CES/WES represented the most sensitive methodology. This study demonstrates the importance of adopting a genomic‐first approach within the diagnosis of adults affected with unsolved rare conditions.
Bibliography:This work was supported by Ministero della Salutes (PNRR‐MR1‐2022‐12376811, RF‐2021‐12374963 and RC‐2024) and Fondazione Bambino Gesù.
Funding
Roberta Petillo, Ilaria De Maggio, Carmelo Piscopo, Massimiliano Chetta, Marina Tarsitano and Luigi Chiriatti contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0009-9163
1399-0004
1399-0004
DOI:10.1111/cge.14715